Counterpoint Mutual Funds’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,620
Closed -$214K 353
2024
Q3
$214K Buy
+2,620
New +$228K 0.04% 271
2023
Q1
Sell
-3,660
Closed -$154K 420
2022
Q4
$154K Buy
3,660
+870
+31% +$36.4K 0.16% 61
2022
Q3
$102K Sell
2,790
-130
-4% -$5.79K 0.25% 189
2022
Q2
$124K Buy
+2,920
New +$139K 0.08% 135
2021
Q4
Sell
-340
Closed -$19K 203
2021
Q3
$19K Buy
340
+140
+70% +$8.52K 0.02% 144
2021
Q2
$13K Buy
+200
New +$12.6K 0.01% 87

Other funds holding LRCX

Counterpoint Mutual Funds's LRCX Position: Q4 2024 in Review

Counterpoint Mutual Funds sold out of Lam Research (LRCX) in Q4 2024, closing a stake of 2,620 shares — an estimated $214K sold.

Counterpoint Mutual Funds first reported a position in LRCX in Q2 2021 and held it in 6 quarters. The position peaked at $214K in Q3 2024. 1,690 funds tracked by Wall St. Rank hold LRCX as of Q4 2024.

  • Counterpoint Mutual Funds reported no remaining Lam Research position as of Q4 2024 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 2,620 Lam Research shares in Q4 2024, an estimated $214K.
  • Counterpoint Mutual Funds first reported a position in Lam Research in Q2 2021 and held it in 6 quarters.
  • Counterpoint Mutual Funds's Lam Research position peaked at $214K in Q3 2024.
  • 1,690 funds tracked by Wall St. Rank held Lam Research as of Q4 2024.

Based on Counterpoint Mutual Funds's 13F filing for Q4 2024, filed 10 Feb 2025.